
Promising New Treatment for Drug-Resistant Epilepsy
A normal, productive life is out of reach for most people with drug-resistant epilepsy. We’re here to change that.

A normal, productive life is out of reach for most people with drug-resistant epilepsy. We’re here to change that.
Incubated at Mayo Clinic and engineered by Cadence, our personalized neuromodulation system was made to fill an unmet need in epilepsy care and bring hope to patients and families.

of the population has epilepsy
people with epilepsy in the U.S.
in costs worldwide
We understand the frustration patients experience, and their hope that a more effective treatment might come along—one that’s customizable, not one-size-fits-all. That’s why we’re creating a system to dramatically reduce seizures, so those who’ve tried everything else can live a more independent life.
* Based on preliminary results
Percentage of patients living seizure free

The Cadence team brings decades of expertise in neuroscience, engineering, and clinical innovation. And, we’re backed by partners and advisors who never lose sight of who we’re working for.
Patient experiences are from a case series conducted using a prototype version of Cadence’s therapy.

Hosted by our CEO and CSO, this podcast shares the journey toward ending epileptic seizures. Kent and Doug’s conversations with expert guests, such as top doctors in neuroscience, investigate the impact epilepsy has and the work being done locally and globally to ensure every person lives a seizure-free life.
Cadence Neuroscience is proud to closely collaborate with Mayo Clinic in raising the standard for epilepsy care. Mayo Clinic’s research and clinical leadership have shaped the evolution of neuromodulation technology where it has been used with success over the past several decades. Cadence’s therapy is using this tested hardware with new software.